<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000572249"><TermName>Zinecard</TermName><TermPronunciation>(ZIH-neh-kard)</TermPronunciation><TermDefinition><DefinitionText>A drug used to reduce heart damage in women given doxorubicin for breast cancer that has spread. It is also being studied in the treatment of cancer. Zinecard contains the active ingredient dexrazoxane. It is a type of cardioprotective agent, a type of chemoprotective agent, and a type of topoisomerase inhibitor.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720791" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Zinecard&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720790" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Zinecard&quot;" language="es" id="_4"/><SpanishTermName>Zinecard</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para disminuir el daño al corazón de las mujeres que toman doxorrubicina para tratar un cáncer de mama que se ha diseminado. Asimismo, está en estudio para el tratamiento de cáncer. Zinecard contiene el ingrediente activo dexrazoxano. Es un tipo de cardioprotector, quimioprotector, e inhibidor de la topoisomerasa.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-10-05</DateFirstPublished><DateLastModified>2008-06-26</DateLastModified></GlossaryTerm>
